Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06688500 · ClinicalTrials.gov registry record
Bowel Dysfunction and HoLEP Outcomes
A clinical trial of Urologic Injuries, sponsored by Northwestern University.
- Recruiting
- Registry status
- 126
- Enrollment target
- 1
- Study location
NCT06688500 is a study of Urologic Injuries that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 126 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06688500, a study of Urologic Injuries, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this prospective study is to examine the correlation and effects of bowel dysfunction on outcomes for patients undergoing holmium laser enucleation of prostate (HoLEP) for lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH).The investigator hypothesizes that patients who have more bowel dysfunction based on higher severity scores on patient-reported validated questionnaires will experience more symptoms in the immediate post-operative period and may have slower recovery of urinary control. Assessment of pre, peri, and post-procedural bowel dysfunction via the Constipation Severity Score (CSS) and Vaizey Incontinence Questionnaire will aid the analysis.
Conditions Studied
Interventions
- PROCEDURE Bowel function post Holmium Laser Enucleation of the Prostate
Study Locations (1)
Illinois
- Northwestern Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2023-10-05 |
| Est. Completion | 2025-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06688500
The ClinicalTrials.gov registry entry for NCT06688500 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urologic Injuries appearing as the primary indexed condition, and to 1 intervention - of which Bowel function post Holmium Laser Enucleation of the Prostate is the first listed.
NCT06688500 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06688500 about?
NCT06688500 is a clinical study titled "Bowel Dysfunction and HoLEP Outcomes". The objective of this prospective study is to examine the correlation and effects of bowel dysfunction on outcomes for patients undergoing holmium laser enucleation of prostate (HoLEP) for lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH).The investigator hypothesizes that...
What is the current status of trial NCT06688500?
This trial is currently recruiting. The enrollment target is 126 participants. The study started on 2023-10-05. Estimated completion is 2025-10-31.
What conditions does trial NCT06688500 study?
This clinical trial studies the following conditions: Urologic Injuries.
What interventions are being tested in trial NCT06688500?
The interventions under investigation include: Bowel function post Holmium Laser Enucleation of the Prostate (PROCEDURE).
Who is sponsoring clinical trial NCT06688500?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06688500 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.